abraxane,paclitaxel
amgen
['sequence,(-consequence)', 'pancreatic']
#asco2022 sequential nab-paclitaxel/gemcitabine followed by modified folfox increase survival compared to standatd nab/gem for first-line metastatic pancreatic cancer : sequence trial by and spanish collaborators